↓ Skip to main content

Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia

Overview of attention for article published in Cochrane database of systematic reviews, December 2012
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (53rd percentile)

Mentioned by

twitter
2 tweeters
f1000
1 research highlight platform

Citations

dimensions_citation
23 Dimensions
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia
Published in
Cochrane database of systematic reviews, December 2012
DOI 10.1002/14651858.cd008891.pub2
Pubmed ID
Authors

Alazzam M, Tidy J, Osborne R, Coleman R, Hancock BW, Lawrie TA, Alazzam, Mo'iad, Tidy, John, Osborne, Raymond, Coleman, Robert, Hancock, Barry W, Lawrie, Theresa A

Abstract

Gestational trophoblastic neoplasia (GTN) is a highly curable group of pregnancy-related tumours; however, approximately 25% of GTN tumours will be resistant to, or will relapse after, initial chemotherapy. These resistant and relapsed lesions will require salvage chemotherapy with or without surgery. Various salvage regimens are used worldwide. It is unclear which regimens are the most effective and the least toxic.

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 January 2013.
All research outputs
#6,802,317
of 12,100,779 outputs
Outputs from Cochrane database of systematic reviews
#5,612
of 7,978 outputs
Outputs of similar age
#130,423
of 290,863 outputs
Outputs of similar age from Cochrane database of systematic reviews
#268
of 358 outputs
Altmetric has tracked 12,100,779 research outputs across all sources so far. This one is in the 42nd percentile – i.e., 42% of other outputs scored the same or lower than it.
So far Altmetric has tracked 7,978 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 14.6. This one is in the 22nd percentile – i.e., 22% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 290,863 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 53% of its contemporaries.
We're also able to compare this research output to 358 others from the same source and published within six weeks on either side of this one. This one is in the 24th percentile – i.e., 24% of its contemporaries scored the same or lower than it.